SIM
RGNX icon

Spark Investment Management’s Regenxbio RGNX Stock Holding History

Spark Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-40,910
Closed -$3.09M – 779
2018
Q3 		$3.09M Buy
+40,910
New +$2.95M 0.18% 181
2016
Q1 		– Sell
-22,900
Closed -$380K – 818
2015
Q4 		$380K Buy
+22,900
New +$455K 0.05% 429

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Spark Investment Management's RGNX Position: Q4 2018 in Review

Spark Investment Management sold out of Regenxbio (RGNX) in Q4 2018, closing a stake of 40,910 shares — an estimated $3.09M sold.

Spark Investment Management first reported a position in RGNX in Q4 2015 and held it in 2 quarters. The position peaked at $3.09M in Q3 2018. 183 funds tracked by Wall St. Rank hold RGNX as of Q4 2018.

  • Spark Investment Management reported no remaining Regenxbio position as of Q4 2018 after selling out during the quarter.
  • Spark Investment Management sold 40,910 Regenxbio shares in Q4 2018, an estimated $3.09M.
  • Spark Investment Management first reported a position in Regenxbio in Q4 2015 and held it in 2 quarters.
  • Spark Investment Management's Regenxbio position peaked at $3.09M in Q3 2018.
  • 183 funds tracked by Wall St. Rank held Regenxbio as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.